Moneycontrol
Get App
SENSEX NIFTY
you are here:

Jenburkt Pharma Ltd.

BSE: 524731 | NSE: | Series: | ISIN: INE354A01013 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info

BSE Live

Jan 20, 13:02
440.00 -13.20 (-2.91%)
Volume
AVERAGE VOLUME
5-Day
2,688
10-Day
3,345
30-Day
1,797
1,258
  • Prev. Close

    453.20

  • Open Price

    453.00

430.00

Today’s L/H

453.00
380.15

52 Wk L/H

560.00
362.60

L/U Price Band

543.80
  • Bid Price (Qty.)

    435.00 (11)

  • Offer Price (Qty.)

    440.00 (15)

  •  VWAP

    436.83
     Beta
    0.40
  • Market Depth (20 Jan 2020)

    BUYSELL
    QTY PRICE PRICE QTY
    11 435.00 440.00 15
    1 430.65 445.90 15
    1 430.50 445.95 2
    25 430.10 446.00 10
    13 430.05 447.95 1
    2360 Total Total 3150
     Market Depth
    BUY 2360
    SELL 3150
    43%
    57%

NSE Live

(%)
Volume
No Data Available
  • Prev. Close

  • Open Price

Today’s L/H

52 Wk L/H

L/U Price Band

  • Bid Price (Qty.)

    ()

  • Offer Price (Qty.)

    ()

  •  VWAP

     Beta
    0.00
  • DELIVERY AVERAGES
    3-Day
    %
    5-Day
    %
    8-Day
    %
    Deliverables
    %
  • SMA
Jenburkt Pharma is not listed on NSE

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

TECHNICAL ANALYSIS

TECHNICAL RATING
Neutral
Moving Averages Neutral
Technical Indicators Neutral
Moving Averages Crossovers Bullish
Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 457.23 461.27 469.33 449.17 445.13 437.07 433.03
Fibonacci 453.79 456.64 461.27 449.17 444.54 441.69 437.07
Camarilla 454.31 455.42 456.53 449.17 452.09 450.98 449.87

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

SIMPLE MOVING AVERAGES
Days BSE
5 442.35
10 447.38
20 423.54
50 415.48
100 423.34
200 459.80
Pivot levels

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Valuation

    • Market Cap (Rs Cr.)
      199.64
    • P/E
      11.76
    • Book Value (Rs)
      168.79
    • Dividend (%)
      102.00
    • Market Lot
      1
    • Industry P/E
      31.15
    • EPS (TTM)
      36.98
    • P/C
      10.89
    • Price/Book
      2.58
    • Dividend Yield.(%)
      2.34
    • Face Value (RS)
      10.00
    • Deliverables (%)
      -

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      199.64
    • P/E
      -
    • Book Value (Rs)
      -
    • Dividend (%)
      102.00
    • Market Lot
      1
    • Industry P/E
      31.15
    • EPS (TTM)
      -
    • P/C
      -
    • Price/Book
      -
    • Dividend Yield.(%)
      2.34
    • Face Value (RS)
      -
    • Deliverables (%)
      -

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Forum

Community Sentiments

Data not Available

What's your call on today?

Read 0 investor views

BUY SELL HOLD

Action in Jenburkt Pharma Ltd.

Pre-Opening Session Prices9:00 am - 9:15 am

BSE - No shares traded
NSE - No shares traded

Financials

Income Statement

  Sep 2019 Jun 2019 Mar 2019 Dec 2018 Sep 2018
Net Sales 34.18 20.84 35.13 32.28 31.98
Other Income 0.86 1.24 0.93 0.67 0.90
PBDIT 7.42 -0.61 8.91 6.36 7.07
Net Profit 5.55 0.06 6.89 4.46 5.74

Balance Sheet

Standalone Mar 2019 Mar 2018
Total Share Capital 4.59 4.59
Networth 77.47 61.26
Total Debt 7.47 0.24
Net Block 9.59 9.57
Investments 5.38 5.42
Total Assets 84.93 61.50

Historical Prices

On
Current Price %Gain / Loss
Open Price 543.00 453.00
-16.57
High Price 543.00 453.00
-16.57
Low Price 515.00 430.00
-16.5
Close Price 525.40 453.20
-13.74
Volume 4,984 1,258
-74.76
On
Current Price %Gain / Loss
No Record Found
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 12264.80 -87.60 -0.71
SENSEX 41657.74 -287.63 -0.69
NIFTY BANK 31279.70 -310.95 -0.98
NIFTY IT 16203.80 -152.80 -0.93
S&P BSE Smallcap 14679.44 -29.26 -0.20
Index Price Change %Chg
Straits Times (Jan 20) 3,276.33 -4.70 -0.14
Shanghai Composite (Jan 20) 3,095.79 20.29 0.66
KOSPI (Jan 20) 2,262.64 12.07 0.54
Nikkei 225 (Jan 20) 24,083.51 42.25 0.18
SGX Nifty (Jan 20) 12,281.50 -101.00 -0.82

CORPORATE ACTION

Date Agenda
Nov 05, 2019 Audited Results
Jul 30, 2019 Quarterly Results
May 28, 2019 Audited Results & Final Dividend
Feb 05, 2019 Quarterly Results
Type Dividend% Ex-Dividend date
Final 102.00 Jul 22, 2019
Final 60.00 Jul 23, 2018
Interim 30.00 Mar 27, 2018
Final 81.00 Jul 21, 2017
Final 9.00 Jul 19, 2016
Ratio Announcement Date Ex-Bonus
No Bonus Information is available for Jenburkt Pharma
Old FV New FV Ex-Split
No Splits Information is available for Jenburkt Pharma
Ratio Premium Ex-Bonus
No Rights Information is available for Jenburkt Pharma
Date Agenda
Jul 30, 2019 -
Jul 31, 2018 -
- Buy Back of Shares
Oct 27, 2017 -
Jul 31, 2017 -

Dividend Summary

For the year ending March 2019 Jenburkt Pharma has declared an equity dividend of 102.00% amounting to Rs 10.2 per share.

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone June 2019 March 2019 December 2018 September 2018
Promoters 45.6 45.6 45.6 45.6
Pledged 0 0 0 0
FII/FPI 2.22 2.22 2.11 1.7
Total DII 8.27 7.95 7.99 7.88
Fin.Insts 0 0 0 0
Insurance Co 0 0 0 0
MF 0 0 0 0
Others DIIs 8.27 7.95 7.99 7.88
Others 43.91 44.23 44.29 44.82
Total 100 100 99.99 100

Mutual Funds Holding

Data not available

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Jenburkt Pharma 435.00 -4.02 560.00 380.15 199.64 122.64 19.80
Sun Pharma 449.10 -1.18 484.10 350.40 107754.13 10,303.21 816.60
Dr Reddys Labs 3056.35 0.75 3067.70 2065.30 50784.72 10,625.50 1,277.30
Divis Labs 1912.90 0.50 1925.25 1460.55 50781.48 4,879.66 1,332.65
Cipla 480.00 -0.05 585.50 389.55 38698.92 12,374.01 1,888.41

COMPANY OVERVIEW

Jenburkt Pharmaceuticals Limited is an India-based company engaged pharmaceutical formulations. The Company is engaged in manufacturing and marketing of speciality and pharmaceutical formulations and healthcare products. The Company manufactures products in two types divsions: consumer divsion and pharmaceutical division. The Company`s products under consumer divsion include nocal tablets, nocal sachet, and nocal granular. The Company`s products uner the pharmaceutical division include anti-arthritic, anti-osteoporotic, antibiotics, anti-diabitic, neuropathy, anti-inflammory analgesics, gastro intenstinal, dermatologicals, aphrodisiac, anti-cough, cold and allergy, anti-ulcerants, and anti-malarial. The Company has approximately 50 brands, which are promoted through doctors.

COMPANY INFORMATION

  • Registered Office

  • Registrars

  • Management

    • Name

      Designation

    • Ashish U Bhuta

      Chairman & Managing Director

    • Dilip H Bhuta

      WholeTime Director & CFO

    • Bharat V Bhate

      Ind. Non-Executive Director

    • Rameshchandra J Vora

      Ind. Non-Executive Director

    • Arun R Raskapurwala

      Ind. Non-Executive Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      No

    • Bse-200

      No

    • S&P CNX 500

      No

    • CNX Midcap

      No

About Jenburkt Pharma Ltd.

Jenburkt Pharma is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 524731.

Related Searches